Daves Julie VanOrsdel 4
4 · DiaMedica Therapeutics Inc. · Filed Jun 2, 2023
Insider Transaction Report
Form 4
Daves Julie VanOrsdel
SVP Clinical Development Oper.
Transactions
- Award
Stock Option (right to buy)
2023-06-01+54,000→ 54,000 totalExercise: $2.73Exp: 2033-05-31→ Common Shares (54,000 underlying)
Holdings
- 0
Voting Common Shares, no par value per share
Footnotes (1)
- [F1]Vests with respect to 25% of the underlying common shares on June 1, 2024 and with respect to the remaining 75% of the underlying common shares vesting quarterly over the following three years commencing on September 1, 2024.